Detail page

Knowledge Web

Person

Thomas Gasser

Neurologe

Name	Thomas Gasser
Place	Deutschland
Gender	männlich
Profession	Neurologe (characteristic profession)
Variant	T. Gasser
Related	Universitätsklinikum Tübingen Hertie-Institut für Klinische Hirnforschung
Further information	Ärztlicher Direktor der Abteilung Neurologie mit Schwerpunkt Neurodegenerative Erkrankungen
Source	Homepage: https://www.medizin.uni-tuebingen.de/de/das-klinikum/mitarbeiter/profil/1598 (Stand: 03.05.2023)
Record type	Person
GND-Identifier	1287760198
Record ID	1287760198
Involved in show all Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease Genotype–phenotype correlation in PRKN-associated Parkinson’s disease Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease Analyse der Expression von SNCA im Hinblick auf die molekulare Entstehung der Parkinson-Krankheit Die Rolle von Varianten in den Genen UQCRC1 und NUS1 bei der Entstehung des Parkinson-Syndroms Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease? Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders The comorbidity and co-medication profile of patients with progressive supranuclear palsy The heterogeneity of Parkinson’s disease Genetic testing for Parkinson’s disease in clinical practice Einführung in die Gentherapie The comorbidity and co-medication profile of patients with progressive supranuclear palsy Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease Genotype–Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature review Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients Das Langlebigkeitsgen Klotho und seine Liquor-Proteinprofile : Modifikator für die Parkinson Erkrankung? Leistungsbasierte Beurteilung der Progredienz kognitiv bedingter Einschränkungen der Aktivitäten des täglichen Lebens bei der Parkinson-Erkrankung Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire PIAS2-mediated blockade of IFN-[beta] signaling: a basis for sporadic Parkinson disease dementia The European Reference Network for Rare Neurological Diseases Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity Genetic architecture of Parkinson's disease in the Indian population: harnessing genetic diversity to address critical gaps in Parkinson's disease research An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial Personalisierte Diagnostik und Therapie in der Neurologie : Chance und Herausforderung Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer’s disease with FDG-PET Personalisierte Therapien bei Parkinson-Syndromen A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias Funktionelle Charakterisierung von zerebellären Purkinjezellen eines Mausmodells des Morbus Niemann-Pick Typ C1 Genetic analysis of Parkinson's disease using Next-generation sequencing Ist eine Mutation im KRAS-Gen der Schlüssel? Special issue “Parkinson’s disease” Genetisch determinierte Dystonien Cholinergic Pathway SNPs and Postural Control in 477 Older Adults. Mechanisms of GBA1 related PD in hiPSC derived neurons Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease Therapie und Verlauf neurologischer Erkrankungen Genetische Risikofaktoren für neuropsychiatrische Erkrankungen Stereotaktische Laserthermokoagulation in der Epilepsiechirurgie Zentren für seltene neurologische Erkrankungen Das Departmentmodell in der neurologischen Universitätsmedizin Dual-Task Performance in GBA Parkinson's Disease Dual-Task Performance in GBA Parkinson’s Disease Einsatz der Next-Generation-Sequenzierung in der Erforschung und molekulargenetischen Diagnostik neurodegenerativer Erkrankungen und Bewegungsstörungen Elucidating projection patterns and postsynaptic partners of medial paracapsular intercalated cells in the mouse amygdala Genetische Untersuchungen zur α-Synuklein-Expression Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen Untersuchung des Einflusses von SNCA-Rep1 auf das Erkrankungsalter und klinische Parameter bei Patienten mit idiopathischem Parkinson-Syndrom Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Thomas Gasser

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers

Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease

Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease

Analyse der Expression von SNCA im Hinblick auf die molekulare Entstehung der Parkinson-Krankheit

Die Rolle von Varianten in den Genen UQCRC1 und NUS1 bei der Entstehung des Parkinson-Syndroms

Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?

Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

The heterogeneity of Parkinson’s disease

Genetic testing for Parkinson’s disease in clinical practice

Einführung in die Gentherapie

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding

Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease

Genotype–Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature review

Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients

Das Langlebigkeitsgen Klotho und seine Liquor-Proteinprofile : Modifikator für die Parkinson Erkrankung?

Leistungsbasierte Beurteilung der Progredienz kognitiv bedingter Einschränkungen der Aktivitäten des täglichen Lebens bei der Parkinson-Erkrankung

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies

Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire

PIAS2-mediated blockade of IFN-[beta] signaling: a basis for sporadic Parkinson disease dementia

The European Reference Network for Rare Neurological Diseases

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Genetic architecture of Parkinson's disease in the Indian population: harnessing genetic diversity to address critical gaps in Parkinson's disease research

An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

Personalisierte Diagnostik und Therapie in der Neurologie : Chance und Herausforderung

Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer’s disease with FDG-PET

Personalisierte Therapien bei Parkinson-Syndromen

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4

Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other Dystonias

Funktionelle Charakterisierung von zerebellären Purkinjezellen eines Mausmodells des Morbus Niemann-Pick Typ C1

Genetic analysis of Parkinson's disease using Next-generation sequencing

Ist eine Mutation im KRAS-Gen der Schlüssel?

Special issue “Parkinson’s disease”

Genetisch determinierte Dystonien

Cholinergic Pathway SNPs and Postural Control in 477 Older Adults.

Mechanisms of GBA1 related PD in hiPSC derived neurons

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease

The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease

Therapie und Verlauf neurologischer Erkrankungen

Genetische Risikofaktoren für neuropsychiatrische Erkrankungen

Stereotaktische Laserthermokoagulation in der Epilepsiechirurgie

Zentren für seltene neurologische Erkrankungen

Das Departmentmodell in der neurologischen Universitätsmedizin

Dual-Task Performance in GBA Parkinson's Disease

Dual-Task Performance in GBA Parkinson’s Disease

Einsatz der Next-Generation-Sequenzierung in der Erforschung und molekulargenetischen Diagnostik neurodegenerativer Erkrankungen und Bewegungsstörungen

Elucidating projection patterns and postsynaptic partners of medial paracapsular intercalated cells in the mouse amygdala

Genetische Untersuchungen zur α-Synuklein-Expression

Therapie und Verlauf neurologischer Erkrankungen

Therapie und Verlauf neurologischer Erkrankungen

Untersuchung des Einflusses von SNCA-Rep1 auf das Erkrankungsalter und klinische Parameter bei Patienten mit idiopathischem Parkinson-Syndrom

Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans